UBS Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.7M | Sell |
602,125
-183,376
| -23% | -$23M | 0.01% | 938 |
|
|
2025
Q1 | $86.9M | Buy |
785,501
+366,073
| +87% | +$40.5M | 0.02% | 812 |
|
|
2024
Q4 | $57.3M | Buy |
419,428
+59,859
| +17% | +$8.17M | 0.01% | 1030 |
|
|
2024
Q3 | $41.4M | Buy |
359,569
+42,642
| +13% | +$4.91M | 0.01% | 913 |
|
|
2024
Q2 | $43.6M | Buy |
316,927
+81,301
| +35% | +$11.2M | 0.01% | 826 |
|
|
2024
Q1 | $32.5M | Buy |
235,626
+91,732
| +64% | +$12.7M | 0.01% | 960 |
|
|
2023
Q4 | $19M | Buy |
143,894
+9,655
| +7% | +$1.27M | 0.01% | 1120 |
|
|
2023
Q3 | $15.1M | Buy |
134,239
+10,938
| +9% | +$1.23M | 0.01% | 1183 |
|
|
2023
Q2 | $11.6M | Sell |
123,301
-1,325
| -1% | -$125K | ﹤0.01% | 1346 |
|
|
2023
Q1 | $12.6M | Sell |
124,626
-92,172
| -43% | -$9.33M | ﹤0.01% | 1241 |
|
|
2022
Q4 | $25.9M | Buy |
216,798
+64,678
| +43% | +$7.73M | 0.01% | 873 |
|
|
2022
Q3 | $16.2M | Buy |
152,120
+68,323
| +82% | +$7.26M | 0.01% | 1024 |
|
|
2022
Q2 | $8.17M | Sell |
83,797
-141,449
| -63% | -$13.8M | ﹤0.01% | 1451 |
|
|
2022
Q1 | $21.1M | Sell |
225,246
-610
| -0.3% | -$57.2K | 0.01% | 1019 |
|
|
2021
Q4 | $19.2M | Buy |
225,856
+54,141
| +32% | +$4.61M | 0.01% | 1138 |
|
|
2021
Q3 | $16.5M | Buy |
171,715
+30,328
| +21% | +$2.91M | 0.01% | 1227 |
|
|
2021
Q2 | $13.8M | Buy |
141,387
+49,514
| +54% | +$4.82M | ﹤0.01% | 1319 |
|
|
2021
Q1 | $8.94M | Buy |
91,873
+76,245
| +488% | +$7.42M | ﹤0.01% | 1525 |
|
|
2020
Q4 | $1.5M | Sell |
15,628
-557
| -3% | -$53.4K | ﹤0.01% | 2844 |
|
|
2020
Q3 | $1.56M | Sell |
16,185
-43,031
| -73% | -$4.14M | ﹤0.01% | 2617 |
|
|
2020
Q2 | $7.23M | Buy |
59,216
+9,120
| +18% | +$1.11M | ﹤0.01% | 1389 |
|
|
2020
Q1 | $4.34M | Sell |
50,096
-24,952
| -33% | -$2.16M | ﹤0.01% | 1601 |
|
|
2019
Q4 | $8.07M | Sell |
75,048
-29,711
| -28% | -$3.19M | ﹤0.01% | 1640 |
|
|
2019
Q3 | $9.44M | Buy |
104,759
+73,000
| +230% | +$6.58M | ﹤0.01% | 1411 |
|
|
2019
Q2 | $2.68M | Sell |
31,759
-11,859
| -27% | -$1M | ﹤0.01% | 2293 |
|
|
2019
Q1 | $3.84M | Sell |
43,618
-104,174
| -70% | -$9.18M | ﹤0.01% | 1946 |
|
|
2018
Q4 | $10.6M | Buy |
147,792
+105,626
| +251% | +$7.54M | ﹤0.01% | 1191 |
|
|
2018
Q3 | $5.18M | Buy |
42,166
+31,256
| +286% | +$3.84M | ﹤0.01% | 1852 |
|
|
2018
Q2 | $1.07M | Sell |
10,910
-50,319
| -82% | -$4.94M | ﹤0.01% | 3021 |
|
|
2018
Q1 | $5.08M | Buy |
61,229
+37,618
| +159% | +$3.12M | ﹤0.01% | 1840 |
|
|
2017
Q4 | $1.83M | Buy |
23,611
+21
| +0.1% | +$1.63K | ﹤0.01% | 2587 |
|
|
2017
Q3 | $1.45M | Sell |
23,590
-10,962
| -32% | -$672K | ﹤0.01% | 2723 |
|
|
2017
Q2 | $1.59M | Sell |
34,552
-9,910
| -22% | -$456K | ﹤0.01% | 2573 |
|
|
2017
Q1 | $1.93M | Sell |
44,462
-212
| -0.5% | -$9.18K | ﹤0.01% | 2379 |
|
|
2016
Q4 | $1.73M | Sell |
44,674
-21,517
| -33% | -$833K | ﹤0.01% | 2397 |
|
|
2016
Q3 | $3.35M | Sell |
66,191
-79,423
| -55% | -$4.02M | ﹤0.01% | 1851 |
|
|
2016
Q2 | $6.62M | Buy |
145,614
+110,364
| +313% | +$5.02M | ﹤0.01% | 1310 |
|
|
2016
Q1 | $1.39M | Sell |
35,250
-19,270
| -35% | -$762K | ﹤0.01% | 2418 |
|
|
2015
Q4 | $3.09M | Buy |
54,520
+38,426
| +239% | +$2.17M | ﹤0.01% | 1868 |
|
|
2015
Q3 | $641K | Buy |
16,094
+59
| +0.4% | +$2.35K | ﹤0.01% | 2936 |
|
|
2015
Q2 | $766K | Buy |
16,035
+4,322
| +37% | +$206K | ﹤0.01% | 2972 |
|
|
2015
Q1 | $466K | Sell |
11,713
-13,447
| -53% | -$535K | ﹤0.01% | 3266 |
|
|
2014
Q4 | $562K | Buy |
+25,160
| New | +$562K | ﹤0.01% | 3119 |
|